Argentum Pharmaceuticals and Bausch Health Settle Patent Dispute Over JUBLIA®
- Wednesday, January 13, 2021, 12:45
- PR Newswire
- Add a comment
NEW YORK, Jan. 13, 2021 /PRNewswire/ — Argentum Pharmaceuticals LLC, a generic pharmaceutical company, announced that it has reached a settlement agreement with Bausch Health US, LLC and Kaken Pharmaceutical Co., LTD., related to Argentum’s inter partes review petition challenging an…
About the Author
admin has written 21874 stories on this site.